OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out PGR/  DE000ME19XP2  /

Stuttgart
2024-09-02  9:27:14 PM Chg.+0.02 Bid10:00:34 PM Ask10:00:34 PM Underlying Strike price Expiration date Option type
11.50EUR +0.17% -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 125.3211 USD 2078-12-31 Call
GlobeNewswire 08-19 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire 08-19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 08-19 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 08-19 CN Issues Lockout Notice to Teamsters
GlobeNewswire 08-15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 08-14 Progressive Reports July 2024 Results
GlobeNewswire 08-14 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire 08-14 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire 08-13 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 08-12 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp 08-12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 08-11 Bank of Russia says rates could reach 20%
GlobeNewswire 08-08 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 08-08 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
GlobeNewswire 08-07 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...
GlobeNewswire 08-07 AGS Unveils its Latest Table Innovation Bonus Spin Xtreme for Poker Rooms and an Exciting New Lineup...
GlobeNewswire 08-07 Team, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
TeleTrader 08-07 Cori Bush loses Missouri Democratic primary
GlobeNewswire 08-06 TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy)...
GlobeNewswire 08-06 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, fo...
TeleTrader 08-06 Aramco's Q2 net income down 3.2% to $29.1 billion
GlobeNewswire 08-05 Progressive Announces Quarterly Common Share Dividend
GlobeNewswire 08-05 NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted...
GlobeNewswire 08-05 Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy
GlobeNewswire 07-30 Progressive Announces Investor Relations Event